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Abstract
We previously documented a ten-fold increase in ccyto-actin expression in dystrophin-deficient skeletal muscle and
hypothesized that increased ccyto-actin expression may participate in an adaptive cytoskeletal remodeling response. To
explore whether increased ccyto-actin fortifies the cortical cytoskeleton in dystrophic skeletal muscle, we generated double
knockout mice lacking both dystrophin and ccyto-actin specifically in skeletal muscle (ms-DKO). Surprisingly, dystrophin-
deficient mdx and ms-DKO mice presented with comparable levels of myofiber necrosis, membrane instability, and deficits
in muscle function. The lack of an exacerbated phenotype in ms-DKO mice suggests ccyto-actin and dystrophin function in a
common pathway. Finally, because both mdx and ms-DKO skeletal muscle showed similar levels of utrophin expression and
presented with identical dystrophies, we conclude utrophin can partially compensate for the loss of dystrophin
independent of a ccyto-actin-utrophin interaction.
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Introduction
Duchenne muscular dystrophy (DMD) is a progressive muscle
wasting disease affecting approximately 1 in every 3500 males [1].
Afflicted males experience a severe dystrophy marked by
wheelchair dependence in the early teens and death due to
cardiac and respiratory failure in the mid to late twenties [2].
DMD results from the loss of dystrophin [3], a 427 kDa protein
localized to the sub-sarcolemmal space of muscle cells [4].
Dystrophin functions to stabilize muscle cell membranes by
binding costameric ccyto-actin [5] and the transmembrane
dystroglycan complex [6–8], thereby linking the costameric
cytoskeleton to the extracellular matrix (ECM) [9,10]. Dystro-
phin-deficiency leads to muscle cell necrosis/regeneration and
muscle weakness [11] due to a heightened susceptibility to muscle
contraction-induced damage [12].
Although the dystrophin-deficient mdx mouse [13] provides a
genetic homologue for DMD, the dystrophy of the mdx mouse is
less severe than presented by DMD patients. Identification of
compensatory proteins responsible for attenuating the phenotype
in mdx mice may be useful for developing new therapeutic targets
for DMD. For example, utrophin, the autosomal homologue of
dystrophin, is upregulated in mdx mice [14–18] and is believed to
mitigate the dystrophin-deficient phenotype due to functional
overlap between utrophin and dystrophin [7,19]. Accordingly,
mice lacking both utrophin and dystrophin (mdx/utrn
2/2) exhibit a
more severe Duchenne-like dystrophy marked by cardiomyopathy
and premature death [20,21]. Moreover, transgenic overexpres-
sion of utrophin rescues all known phenotypes of the mdx mouse
[22]. Collectively, these results suggest increased utrophin
expression can partially compensate for the loss of dystrophin in
the mdx mouse.
While utrophin can functionally replace dystrophin, there is
evidence suggesting alternative pathways between the ECM and
cytoskeleton are fortified in dystrophin-deficient muscle. Levels of
a7 integrin, a transmembrane protein that complexes with adapter
proteins to link the actin cytoskeleton to the ECM, are increased in
both DMD patients and the mdx mouse [23]. The severe phenotype
of mice lacking both dystrophin and a7 integrin [24] and the ability
of transgenic a7 integrin overexpression to increase lifespan in mdx/
utrn
2/2 mice [25] suggests increased a7 integrin expression fortifies
a parallel structural link between the ECM and the cytoskeleton in
dystrophin-deficient muscle.In addition, plectin, a large cytoskeletal
linker protein, was recently reported to link the dystrophin-
glycoprotein complex to the intermediate filament cytoskeleton
and plectin levels are also reported to be elevated in dystrophin-
deficient muscle [26]. In summary, these data suggest loss of
dystrophin results in a cytoskeletal remodeling response to bolster
the weakened attachment of the ECM to the cytoskeleton.
We recently demonstrated ccyto-actin expression is elevated
approximately ten-fold in dystrophin-deficient muscle and hy-
pothesized that the upregulated ccyto-actin functions to reinforce
the weakened cytoskeleton by interacting with costameric proteins
such as utrophin, the a7 integrin complex, and plectin [27].
Although the function of ccyto-actin in dystrophic muscle has yet to
be determined, we showed ccyto-actin expression is required for
muscle cell viability as muscle-specific ccyto-actin knockout mice
develop a progressive myopathy associated with myofiber necrosis
and regeneration along with costamere disorganization and
functional deficits [28].
PLoS ONE | www.plosone.org 1 June 2008 | Volume 3 | Issue 6 | e2419To determine if elevated ccyto-actin expression stabilizes parallel
linkages between the ECM and cytoskeleton in dystrophin-
deficient skeletal muscle, we generated mice lacking both ccyto-
actin and dystrophin by breeding the conditional Actg1 allele [28]
to the mdx background (ms-DKO). No significant differences were
measured in dystrophic histological parameters, membrane
permeability, and muscle performance when mdx and ms-DKO
mice were compared, suggesting ccyto-actin and dystrophin
function in a common pathway. Increased plectin expression
was not found to explain the lack of an exacerbated phenotype in
ms-DKO mice. However, utrophin expression was equivalently
elevated in mdx and ms-DKO skeletal muscle and co-purified with
b-dystroglycan. These results indicate utrophin can partially
abrogate dystrophic phenotypes in mdx skeletal muscle in the
absence of a direct link to ccyto-actin filaments.
Results and Discussion
Expression and localization of cytoplasmic actins in mdx
and ms-DKO skeletal muscle
To assess the effects of increased ccyto-actin expression in
dystrophin-deficient muscle, mice harboring the floxed Actg1 allele
[28] and an HSA-Cre transgene [29] were bred to the mdx
background to generate mice lacking ccyto-actin and dystrophin in
skeletal muscle (ms-DKO). Subsequently, expression levels of actin
isoforms were determined by western blot analysis of actin
extractions from skeletal muscle (Fig. 1A). Consistent with previous
findings [27], one-year old mdx mice showed increased ccyto-actin
expression in skeletal muscle extracts compared to wt (7.160.7
fold increase). However, one-year old ms-DKO mice surprisingly
showed elevated ccyto-actin expression in skeletal muscle extracts
compared to wt (3.660.8 fold increase, Fig. 1B). Both mdx and ms-
DKO mice showed dramatic elevations in bcyto-actin expression in
skeletal muscle extracts when compared to wt (13.861.4 and
8.160.9 fold respectively) (Fig. 1 B). However, no changes in
expression levels of either asm-or csm-actin were measured (Fig. 1
A and B).
To determine what cell type was responsible for increased ccyto-
actin and bcyto-actin expression in mdx and ms-DKO skeletal
muscle extracts, immunofluorescence analysis of quadriceps cross
sections was conducted. Small pockets of strong immunoreactivity
were observed for both cytoplasmic actins, which appeared to be
macrophages invading necrotic fibers (Fig. S1 and Fig. 1 C).
Colocalization between a macrophage marker (Mac-1) and both
cytoplasmic actins was observed (Fig. S1 and Fig. 1 D), suggesting
the elevated cytoplasmic actin expression detected in mdx and ms-
DKO skeletal muscle extracts was in part due to macrophage
infiltration.
We next quantified the number of macrophages present in wild
type, ccyto-actin muscle-specific knockout [28] (Actg1 ms-KO), mdx,
and ms-DKO skeletal muscle to determine if ccyto-actin expression
correlates with inflammatory cell infiltration. Because wt skeletal
muscle shows low levels of ccyto-actin expression and Actg1 ms-KO
skeletal muscle shows no ccyto-actin expression, we expected to
observe low levels of acid-phosphatase positive macrophages in wt
and Actg1 ms-KO skeletal muscle. As expected, the number of
macrophages present in wt and Actg1 ms-KO skeletal muscle was
significantly less than the number of macrophages present in mdx
and ms-DKO skeletal muscle (Fig. 2 A and B). Because mdx and
ms-DKO skeletal muscle showed identical levels of macrophage
infiltration, we conclude that approximately half of the ccyto-actin
expressed in mdx skeletal muscle extracts (mdx 7.1 fold increase vs.
ms-DKO 3.6 fold increase over wt) can be attributed to
macrophage infiltration.
To more definitely test the hypothesis that residual ccyto-actin
expression in ms-DKO skeletal muscle was solely due to
macrophage infiltration, we measured ccyto-actin expression in
muscle extracts from 2.5 week old mice, which is prior to the onset
of dystrophy (Fig. 2C). Western blot analysis of actin extractions of
skeletal muscle from 2.5 week mice showed detectable ccyto-actin
Figure 1. Expression and localization of actin isoforms in
skeletal muscle. (A) Representative western blots of actin isoforms
from actin-rich elutes from wt, mdx, and ms-DKO skeletal muscle. (B)
Quantification of differential actin isoform expression normalized to ast-
actin. Error bars represent SEM. (C) Ten micron thick cryosections from
ms-DKO quadriceps muscle stained with antibodies to bcyto-actin, ccyto-
actin, and laminin to show focal regions of strong cytoplasmic actin
immunoreactivity. (D) Ten micron cryosections from ms-DKO quadri-
ceps show colocalization between a marcophage marker (Mac-1) and
both cytoplasmic actins.
doi:10.1371/journal.pone.0002419.g001
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(Fig. 2D). These results demonstrate that ccyto-actin expression
detected in ms-DKO skeletal muscle extracts was due to
macrophage infiltration.
The mdx phenotype is not exacerbated by muscle-
specific ablation of ccyto-actin
To determine if ms-DKO mice were more dystrophic than mdx
mice, muscle cell death and regeneration was quantified by
determining the proportion of centrally nucleated fibers in
quadriceps muscles at 1, 3, and 12 months of age. At all
timepoints examined, mdx and ms-DKO mice showed comparable
levels of histopathology (Fig. 3A) and equivalent levels of muscle
cell death and regeneration (Fig. 3B). Accordingly, the mean
muscle-fiber diameter of mdx (31.1360.499 mm) and ms-DKO
(29.9960.479 mm) triceps muscles was significantly smaller than
the mean muscle-fiber diameter in wt triceps muscle (38.3760.464
mm) (Fig. 3C). Muscle cell membrane fragility of mdx and ms-DKO
did not differ as demonstrated by comparable levels of serum
phosphocreatine kinase (Fig. 3D).
To determine how loss of both ccyto-actin and dystrophin
affected muscle performance in vivo, whole body tension analysis
was conducted on mice at three months and twelve months of age.
At three months of age, wt mice (WBT1 122.267.7 mN/g and
WBT1–5 111.866.9 mN/g) produced significantly more pulling
force than both mdx (WBT1 67.262.7 mN/g and WBT1–5
61.862.7 mN/g) and ms-DKO mice (WBT1 76.8611.1 mN/g
and WBT1–5 69.6610.8 mN/g). At twelve months of age, wt mice
(WBT1 105.567.2 mN/g and WBT1–5 94.765.3 mN/g) gener-
ated significantly more pulling force than both mdx (WBT1
67.665.4 mN/g and WBT1–5 54.366.1 mN/g) and ms-DKO
mice (WBT1 79.567.3 mN/g and WBT1–5 67.766.4 mN/g). The
force generated by mdx mice was not significantly different from
the force generated by ms-DKO mice at either age examined
(Fig. 4).
To more precisely probe muscle function, contractile properties
of isolated extensor digitiorum longus muscles were determined.
Consistent with the results from in vivo force analysis, mdx and ms-
DKO muscle showed similar deficiencies in twitch force (Fig. 5A),
maximal force production (Fig. 5B), and normalized maximal
force production (Fig. 5C) when compared to wt. In addition,
susceptibility to damage caused by eccentric contractions (Fig. 5D)
was comparable in mdx and ms-DKO muscle. Taken together, the
finding that mdx and ms-DKO muscle function is indistinguishable
both in vivo and ex vivo indicates increased ccyto-actin expression
does not improve mdx muscle function. Collectively, the results of
Figs. 3–5 demonstrate that the established parameters of
dystrophin-deficiency in mdx mice were not significantly worsened
by skeletal muscle-specific ablation of ccyto-actin.
Assessment of compensatory proteins in mdx and ms-
DKO skeletal muscle
To assess expression levels of dystrophin-associated glycopro-
teins (DAG), KCl-washed microsomes were prepared from wt,
mdx, and ms-DKO mice for western blot analysis. a-Sarcoglycan,
c-sarcoglycan, and b-dystroglycan expression levels were similarly
reduced approximately 75–80% in mdx and ms-DKO microsomes
when compared to wt microsomes (Fig. 6). The finding that
utrophin and not plectin expression levels were increased in mdx
and ms-DKO microsomes when compared to wt microsomes
(3.761.0 and 4.561.5 fold increases respectively), suggested that
increased utrophin expression stabilizes low levels of DAG at mdx
Figure 2. ccyto-actin expression correlates with inflammation. (A) Acid phosphatase stained skeletal muscle sections from wt, ccyto-actin
muscle-specifc knockout (Actg1 ms-KO), mdx, and ms-DKO. Arrows indicate acid phosphatase positive macrophage. (B) Quantification of macrophage
infiltrants in wt, Actg1 ms-KO, mdx, and ms-DKO muscle sections. The asterisk denotes a statistically significant difference from wt, pound sign
denotes statistically significant difference from Actg1 ms-KO (p,0.05). Error bars represent SEM. (C) H&E-stained quadriceps sections from 2.5 week
old mdx and ms-DKO. Both mice show minimal histological abnormalities. (D) Western blots of actin-elutes from 2.5 week old mdx and ms-DKO
skeletal muscle. ccyto-actin is not detected in ms-DKO muscle prior to the onset of dystrophy.
doi:10.1371/journal.pone.0002419.g002
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report [27], we observed elevated ccyto-actin levels in mdx
microsomes when compared to wt microsomes (9.863.0 fold
increase). However, ccyto-actin was also elevated in ms-DKO
microsomes when compared to wt microsomes (5.162.6 fold
increase), which suggested nonmuscle cell types contributed to
approximately half of the observed increase in ccyto-actin
expression in mdx microsomes. Contaminants by nonmuscle cells
types also likely explains the elevated levels of bcyto-actin in mdx
and ms-DKO microsomes when compared to wt microsomes
(18.362.2 and 18.162.0 fold increases respectively) (Fig. 6).
To further investigate whether plectin or utrophin may
compensate for the loss of dystrophin, relative expression levels
in wt, mdx, and ms-DKO skeletal muscle was examined by western
blot analysis of SDS-extracted skeletal muscle. At all ages
examined, only utrophin expression was elevated in mdx and ms-
DKO skeletal muscle when compared to wt skeletal muscle (Fig. 7
A and B). Next, we subjected solubilized mdx and ms-DKO skeletal
muscle extracts to wheat-germ agglutinin chromatography to
determine if plectin or utrophin co-purified with b-dystroglycan
(Fig. 7C). Only utrophin co-purified with b-dystroglycan in mdx
skeletal muscle and ms-DKO skeletal muscle (Fig. 7D). In
summary, these data suggest utrophin compensates for the loss
of dystrophin through a ccyto-actin independent mechanisms.
Concluding remarks
Identifying proteins that can functionally compensate for the
loss of dystrophin is important because strategies to upregulate
such proteins may have therapeutic potential for the treatment of
DMD. Recently, we identified a ten-fold increase in ccyto-actin
expression in dystrophin-deficient muscle and hypothesized that
elevated ccyto-actin expression may partially strengthen dystro-
Figure 3. Dystrophic parameters were not exaberated in ms-DKO mice. (A) H&E-stained quadriceps sections from mdx and ms-DKO at 1, 3,
and 12 months of age. Both mice show comparable levels of myofiber necrosis. (B) Quantification of proportion of centrally nucleated fibers in
quadricepts muscle of mdx and ms-DKO mice at 1, 3, and 12 months of age. (C) Box and whisker blots showing the distribution of myofiber diameters
from 12 month old triceps muscle from wt, mdx and ms-DKO mice. An asterisk denotes a significant difference in mean fiber diameter from wt mice
(p,0.05). (D) Analysis of membrane permeability by quantifying serum levels of creatine phosphokinase. Error bars represent SEM in (B) and (D).
doi:10.1371/journal.pone.0002419.g003
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ECM and cytoskeleton [27]. To determine if increased ccyto-actin
expression stabilizes the cortical actin cytoskeleton in dystrophin-
deficient skeletal muscle, we generated mice lacking dystrophin
and conditionally lacking ccyto-actin in skeletal muscle (ms-DKO).
Surprisingly, the phenotype of mdx and ms-DKO mice was
identical as demonstrated by comparable levels of muscle cell
death and regeneration, muscle membrane fragility, and muscle
weakness. These results suggest increased ccyto-actin expression
does not fortify dystrophin-deficient muscle cell membranes, but
ccyto-actin and dystrophin lie in the same functional pathway.
Consistent with previous results, utrophin co-purified with b-
dystroglycan [15] and showed increased expression in mdx skeletal
muscle [14–18]. We also showed utrophin co-purified with b-
dystroglycan and showed expression levels comparable to mdx in
ms-DKO skeletal muscle. Collectively, these results imply utrophin
does not need to interact with ccyto-actin to attenuate dystrophic
phenotypes in mdx skeletal muscle.
Materials and Methods
Generation of mice
Mice harboring the conditional Actg1 allele were described
previously [28] and subsequently backcrossed a minimum of five
generations to the C57BL/6 background. These mice were
crossed to mice expressing cre recombinase under control of the
human ask-actin promoter (HSA-Cre mice were provided by Dr.
Judith Melki, INSERM, France) [29] to generate mice that were
homozygous for the floxed Actg1 allele and hemizygous for HSA-
Cre. These mice were backcrossed to the mdx background two
generations to isolate mice with the genotype Actg1
flox/flox HSA-
Cre mdx or Actg1
flox+neo/flox+neo HSA-Cre mdx. Both mice showed
similar phenotypes so their results were pooled. Genotypes of the
Actg1 locus and presence of the cre transgene were determined
using PCR as described [28]. All animals were housed and treated
in accordance with the standards set forth by the University of
Minnesota Institutional Animal Care and Use Committee.
Antibodies
Antibodies to ccyto-actin were described earlier (pAb 7577 and
mAb 2-4) [27]. A polyclonal antibody (pAb) to bcyto-actin was
generated by injecting rabbits with a peptide mimicking the amino
terminus of bcyto-actin (2963). pAb 2963 was then affinity purified
using platlet actin (Cytoskeleton Inc catalogue number APHL99)
as described previously [30]. Monoclonal antibodies to bcyto-actin
(AC-15 catalogue number A1978), asm-actin (1A4 catalogue
number A5228), ast-actin (5C5 catalogue number A2172), a-
tubulin (B512 catalogue number T6074), and laminin (4H8-2
catalogue number L0663) were purchased from Sigma. The
monoclonal csm-actin antibody (B4) was provided as a kind gift
from Dr. James Lessard. The monoclonal Mac-1 antibody (CD
11b) was provided as a kind gift from Dr. Melissa Spencer. The
polyclonal utrophin antibody (103) was provided from Dr. Stanley
Froehner. The polyclonal plectin antibody (46) was a kind gift
from Dr. Gerhard Wiche. The dystrophin (catalogue number
NCL-DYS2), a-sarcoglycan (catalogue number NCL-a-SARC),
and the c-sarcoglycan (catalogue number NCL-g-SARC) were
purchased from Novacastra. The b-dystroglycan antibody (mAb
43DAG-1, catalogue number VP-B205) was purchased from
Vector Laboratories. The monoclonal Na
+/K
+ ATPase antibody
(McB2) was described previously [31]. Infrared dye-conjugated
anti-mouse and anti-rabbit antibodies were purchased from LI-
COR Biosciences (catalogue numbers 926-32223 and 926-32210).
Alexa-488- or 568-conjugated anti-rabbit and anti-rat 2u antibod-
ies were purchased from Molecular Probes (catalogue numbers
A11034 and A11077).
Muscle Extracts
Muscle was harvested from anesthetized mice immediately
following cervical dislocation and snap frozen in liquid N2. SDS-
extracts of muscle were performed as described [27]. Protein
concentration was determined using the BioRad DC Protein Assay
(catalogue numbers 500-0111, 500-0112, and 500-0116). KCl-
washed microsomal preparations were generated as described [32]
and protein concentration was quantified using a Lowry Assay
(Pierce catalogue number 23240). Actin preparations from skeletal
muscle were collected by subjecting muscle to a low-salt extraction
and DNase-1 amplification protocol [27].
Western blot analysis and quantification
To determine changes in protein expression in total muscle and
microsomal fractions, 25 mg of protein was subjected to SDS-
PAGE and transferred to nitrocellulose. Nitrocellulose membranes
Figure 4. Analysis of force production in vivo. Whole body tension
analysis on 3 month old (A) and 11–12 month old mice (B). Averages of
the maximal pulling force (WBT1) and the top five pulling forces
(WBT1–5) are represented graphically. Error bar represents the SEM.
Asterisk indicates a statisically significant different outcome from wt
(p,0.05).
doi:10.1371/journal.pone.0002419.g004
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buffered-saline (PBS) for one hour at room temperature.
Membranes were then incubated with primary antibodies
overnight at room temperature (primary antibody dilutions:
mAb 2-4 (1:1000), mAb AC-15 (1:500), mAb 1A4 (1:250), mAb
B4 (1:250), mAb 5C5 (1:2000), mAb DYS2 (1:50), pAb 103
(1:250), pAb 46 (1:3000), mAb 43DAG-1 (1:50), mAb NCL-a-
SARC (1:50), mAb NCL-g-SARC (1:50), mAb McB2 (1:100), and
mAb B512 (1:1000)). Membranes were washed in 5% milk
solution in PBS ten minutes two times at room temperature and
then incubated with IR-dye conjugated secondary antibodies
(1:10,000 dilution) for 30 minutes at room temperature. Then,
membranes were washed in a 0.1% triton solution in PBS for ten
minutes two times to remove excess secondary antibody. Western
blots were imaged and quantified with an Odyssey Infrared
Imaging System (LI-COR Biosciences catalogue number 9201-
01). The normalizing signal in SDS-extracts was a-tubulin while
Na
+/K
+ ATPase was used in microsomal fractions.
Immunofluorescence microscopy
Individual muscles were dissected, coated in OCT (TissueTek
catalogue number 4583), and then frozen in melting isopentane.
Ten micron transverse sections were cut on a Leica CM3050
cryostat, air dried, then fixed in 4% paraformaldehyde for
10 minutes. Sections were washed with PBS, blocked in 5% goat
serum for 30 min, and incubated with 1u antibodies overnight at
4u C (primary antibody dilutions: pAb 7577 (1:50), pAb 2963 (1:1)
mAb 4H8-2 (1:250), and mAb Mac-1 (1:100)). Sections were then
washed/blocked with 5% goat serum for 10 min 3 times and then
incubated with Alexa-488- or 568-conjugated 2u antibodies
(1:1000 dilution) for 30 min at 37uC. Then, sections were washed
with PBS and coverslips were applied with a drop of Anti-Fade
Reagent (Molecular Probes catalogue number P36930). Confocal
images were collected on a Bio-Rad MRC 1000 scan head
mounted on an upright Nikon Optishot microscope at the
University of Minnesota Biomedical Image Processing Lab.
Images were equivalently processed using Adobe Photoshop.
Assessment of dystrophic parameters
Tenmicronthickcryosectionsofquadriceps,tibialis anterior,and
triceps were stained with hematoxylin and eosin-phloxine as
described [33]. Four images from different areas of the muscle
section were collected on a Zeiss Axiovert 25 microscope using
ImagePro Software. These images were imported into Scion Image
to determine the proportion of centrally nucleated fibers (800–1000
fibers counted/muscle) at 1, 3, and 12 month old mice (n=4 for
each genotype at each timepoint). Fiber diameter distribution was
determined in 12 month old triceps sections as described [33] from
at least 700 fibers/genotype. Membrane permeability was deter-
mined by quantifying serum creatine kinase levelson Vitros CK DT
slides (Ortho-Clinical Diagnostics catalogue number DT1975580)
using a Kodak Ektachem DT60 analyzer.
Figure 5. Contractile properties of isolated extensor digitorum longus muscles. Examination of normalized twitch force (A), maximal
tetanic force (B), normalized maximal tetanic force (C), and susceptibility to damage caused by eccentric contractions (D). Both mdx and ms-DKO
extensor digitorum longus muscles showed significant decrements when compared to wt extensor digitorum longus muscles. (*) indicates p,0.05
when compared to wt.
doi:10.1371/journal.pone.0002419.g005
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Ten micron thick cryosections from either quadriceps or
gastrocnemius (4 sections per genotype) were subjected to an Acid
Phosphatase stain. Briefly, sections were incubated in Acid
Phosphatase buffer (98 mM Napthol AS-BI Phosphate, 0.046 M
Sodium Acetate, 0.15% Pararosaniline, and 0.58 M Sodium
Nitrite pH 5.0) for two hours at 37uC. Sections were washed
extensively and then counterstained with Gills Hematoxylin and
mounted in Permount (Fisher Scientific catalogue number SP15-
100). Montages of muscle sections were collected on a Zeiss
Microscope mounted with a Leica DFC300 FX camera. The
entire muscle section was examined and the number of Acid
Phosphatase-positive macrophage were counted and normalized
to section area (mm
2) using Image Pro Plus Software.
Whole body tension
Mice were subjected to whole body tension as described [28]. At
3 months of age 5 wild type, 5 mdx, and 4 ms-DKO mice were
subjected to analysis. At 11 to 12 months of age 5 wild type mice, 7
mdx, and 7 ms-DKO mice were analyzed.
Contractile properties of isolated extensor digitorum
longus
11–12 month old mice were anesthetized and the extensor
digitorum longus muscle was removed (n=4 mice per genotype).
The proximal tendon was attached to 4-0 suture silk to a dual-
mode muscle lever system (model 300B-LR Aurora Scientific,
Aurora, ON, Canada). Muscles were equilibrated for 10 minutes
in a bath assembly containing Krebs-Ringer-bicarbonate buffer
(119 mM NaCl, 5.0 KCl mM, 1.0 MgSO4 mM, 12.25 NaHCO3
mM, 1.0 CaCl2 mM, 1.0 mM KH2PO4, 10.0 mM glucose,
0.17 mM leucine, 0.10 mM isoleucine, 0.20 mM valine plus 10
mg/ml gentammicin sulfate and 0.10 U/ml insulin) at 25uC while
being constantly oxygenated with 95% O2/5% CO2 gas. Then,
the resting tension was set to 0.4 g and twitch force was
determined by stimulating the muscle with a 0.5 ms pulse at
150 V (Grass stimulator, Grass Telefactor, Warwick, RI). Thirty
seconds later the muscle was stimulated to twitch again and the
greater of two contractions was recorded. Tetanic contractions
were elicited by stimulating the muscle with 150 V for 200 ms at
180 Hz. The greater of two contractions separated by two minutes
of recovery time was recorded. To determine damage caused by
eccentric contractions, muscles were subjected to five lengthening
contractions at three minute intervals. Each ECC consisted of a
maximal tetanic stimulation for 200 ms accompanied by a stretch
of 0.5 Lo/s to give a total stretch of 0.1Lo. Force drop was
calculated as ((ECC1-ECC5)/ECC1)). Results from both EDL
muscles of one mouse were averaged to give a single data point.
Wheat germ agglutinin chromatography
To determine interactions with b-dystroglycan, 100 mg of
skeletal muscle was solubulized in 1 mL of 1% digitonin solution
(1% Digitonin, 50 mM Tris HCl, 500 mM NaCl, and protease
inhibitor [Roche catalogue number 4693116]). These samples
were then centrifuged at 100,000g for 40 minutes and the soluble
fraction was added to agarose-coupled wheat germ agglutinin
beads (Sigma catalogue number 61768), which were pre-
equilibrated with wash buffer (0.1% Digitonin, 50 mM Tris-
HCl, 500 mM NaCl, 64 mM Benzamidine, and 20 mM PMSF),
and incubated for 2 hours at 4uC. Beads were pelleted, washed,
and then eluted by incubating beads with Laemmli buffer in
boiling water.
Statistical analysis
All data are presented as mean 6 standard error of the mean.
Comparisons between groups was performed using a One-way
ANOVA accompanied by a Tukey post hoc test to determine
significance (p,0.05).
Supporting Information
Figure S1 Localization of cytoplasmic actins in mdx quadriceps
sections. (A) Ten micron thick sections from mdx quadriceps
stained with laminin and cytoplasmic actin antibodies. Strong
immunoreactivity was observed in what appeared to be macro-
phages invading necrotic fibers. (B) Ten micron thick sections from
mdx quadriceps stained with a macrophage marker (Mac-1) and
cytoplasmic actins. Colocalization between cytoplasmic actins and
a macrophage marker (Mac-1) was observed.
Found at: doi:10.1371/journal.pone.0002419.s001 (8.34 MB TIF)
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